title: Brain Tumors: The Influence of Tumor Type and Routine MR Imaging Characteristics at BOLD Functional MR Imaging in the Primary Motor Gyrus.
abstract: Purpose To evaluate the effects of histologic features and anatomic magnetic resonance (MR) imaging characteristics of brain tumors on the functional MR imaging signal in the primary motor cortex (PMC), as false-negative blood oxygen level-dependent (BOLD) functional MR imaging activation can limit the accurate localization of eloquent cortices. Materials and Methods Institutional review board approval was obtained, and informed consent was waived for this HIPAA-compliant retrospective study. It comprised 63 patients referred between 2006 and 2014 for preoperative functional MR imaging localization of the Rolandic cortex. The patients had glioblastoma multiforme (GBM) (n = 20), metastasis (n = 21), or meningioma (n = 22). The volumes of functional MR imaging activation were measured during performance of a bilateral hand motor task. Ratios of functional MR imaging activation were normalized to PMC volume. Statistical analysis was performed for the following: (a) differences between hemispheres within each histologic tumor type (paired Wilcoxon test), (b) differences across tumor types (Kruskal-Wallis and Fisher tests), (c) pairwise tests between tumor types (Mann-Whitney U test), (d) relationships between fast fluid-attenuated inversion recovery (FLAIR) data and enhancement volume with activation (Spearman rank correlation coefficient), and (e) differences in activation volumes by tumor location (Mann-Whitney U test). Results A significant interhemispheric difference was found between the activation volumes in GBMs (mean, 511.43 voxels ± 307.73 [standard deviation] and 330.78 voxels ± 278.95; P < .01) but not in metastases (504.68 voxels ± 220.98 and 460.22 voxels ± 276.83; P = .15) or meningiomas (424.07 voxels ± 247.58 and 415.18 voxels ± 222.36; P = .85). GBMs showed significantly lower activation ratios (median, 0.49; range, 0.04-1.15) than metastases (median, 0.79; range, 0.28-1.66; P = .043) and meningiomas (median, 0.91; range, 0.52-2.05; P < .01). There was a moderate correlation with the volumes of FLAIR abnormality in metastases (ρ = -0.50) and meningiomas (ρ = -0.55). Enhancement volume (ρ = -0.11) and tumor distance from the PMC (median, 0.73 and range, 0.04-2.05 for near and median, 0.82 and range, 0.39-1.66 for far; P = .14) did not influence activation. Conclusion BOLD functional MR imaging activation in the ipsilateral PMC is influenced by tumor type and is significantly reduced in GBMs. FLAIR abnormality correlates moderately with the activation ratios in metastases and meningiomas.©RSNA, 2016 Online supplemental material is available for this article.
authors.affiliation: From the Functional MRI Laboratory, Department of Radiology (V.H.F.d.A., K.K.P., N.M.P., A.I.H.), the Department of Medical Physics (K.K.P.), the Department of Epidemiology-Biostatistics (K.M.W.), and the Brain Tumor Center (A.I.H.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065; and the Department of Radiology, Vestfold Hospital Trust, Tønsberg, Norway (V.H.F.d.A.).
authors.forename: Vitor Hugo
authors.initials: VH
authors.lastname: Fraga de Abreu
authors.affiliation: From the Functional MRI Laboratory, Department of Radiology (V.H.F.d.A., K.K.P., N.M.P., A.I.H.), the Department of Medical Physics (K.K.P.), the Department of Epidemiology-Biostatistics (K.M.W.), and the Brain Tumor Center (A.I.H.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065; and the Department of Radiology, Vestfold Hospital Trust, Tønsberg, Norway (V.H.F.d.A.).
authors.forename: Kyung K
authors.initials: KK
authors.lastname: Peck
authors.affiliation: From the Functional MRI Laboratory, Department of Radiology (V.H.F.d.A., K.K.P., N.M.P., A.I.H.), the Department of Medical Physics (K.K.P.), the Department of Epidemiology-Biostatistics (K.M.W.), and the Brain Tumor Center (A.I.H.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065; and the Department of Radiology, Vestfold Hospital Trust, Tønsberg, Norway (V.H.F.d.A.).
authors.forename: Nicole M
authors.initials: NM
authors.lastname: Petrovich-Brennan
authors.affiliation: From the Functional MRI Laboratory, Department of Radiology (V.H.F.d.A., K.K.P., N.M.P., A.I.H.), the Department of Medical Physics (K.K.P.), the Department of Epidemiology-Biostatistics (K.M.W.), and the Brain Tumor Center (A.I.H.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065; and the Department of Radiology, Vestfold Hospital Trust, Tønsberg, Norway (V.H.F.d.A.).
authors.forename: Kaitlin M
authors.initials: KM
authors.lastname: Woo
authors.affiliation: From the Functional MRI Laboratory, Department of Radiology (V.H.F.d.A., K.K.P., N.M.P., A.I.H.), the Department of Medical Physics (K.K.P.), the Department of Epidemiology-Biostatistics (K.M.W.), and the Brain Tumor Center (A.I.H.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065; and the Department of Radiology, Vestfold Hospital Trust, Tønsberg, Norway (V.H.F.d.A.).
authors.forename: Andrei I
authors.initials: AI
authors.lastname: Holodny
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000473:pathology* / Q000503:physiopathology; D005260:Female; D005909:Glioblastoma / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008579:Meningioma / Q000473:pathology* / Q000503:physiopathology; D008875:Middle Aged; D009044:Motor Cortex / Q000473:pathology* / Q000503:physiopathology; D009362:Neoplasm Metastasis; D009483:Neuropsychological Tests; D009929:Organ Size / Q000502:physiology; D012189:Retrospective Studies; D055815:Young Adult